• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2015 HAYES, Inc. Magnetic sphincter augmentation (LINX Reflux Management System) for treatment of gastroesophageal reflux disease
2015 HAYES, Inc. Nivolumab (Opdivo) for first-line treatment of advanced melanoma
2015 HAYES, Inc. Physical therapy for chronic pelvic pain
2015 HAYES, Inc. Rolapitant (Varubi) in combination with other antiemetic drugs to prevent delayed nausea and vomiting from cancer chemotherapy
2015 HAYES, Inc. Use of anti-infliximab antibody levels to monitor infliximab treatment in patients with inflammatory bowel disease (IBD)
2015 HAYES, Inc. Wireless pulmonary artery pressure monitoring with CardioMEMS HF System (St. Jude Medical) for management of chronic heart failure
2015 HAYES, Inc. Zio patch (iRhythm Technologies Inc.) for long-term ambulatory cardiac rhythm monitoring
2015 HAYES, Inc. CancerTYPE ID
2015 HAYES, Inc. ConfirmMDx for prostate cancer
2015 HAYES, Inc. know error DNA Specimen Provenance Assay (Strand Diagnostics)
2015 HAYES, Inc. Oncotype DX Colon Cancer Assay
2015 HAYES, Inc. Prosigna Breast Cancer Prognostic Gene Signature Assay
2015 HAYES, Inc. Tissue of Origin Test (ResponseDX)
2015 HAYES, Inc. Autologous stem cell therapy for treatment of avascular necrosis of the hip
2015 HAYES, Inc. Cryoablation for treatment of non-small cell lung cancer
2015 HAYES, Inc. Full-field digital mammography for breast cancer screening
2015 HAYES, Inc. Intraoperative radiotherapy for treatment of early-stage breast cancer
2015 HAYES, Inc. Metal-on-metal hip resurfacing arthroplasty versus total hip replacement for osteoarthritis
2015 HAYES, Inc. MRI-TRUS fusion-guided biopsy for the diagnosis of prostate cancer
2015 HAYES, Inc. K9 inhibitors for cholesterol reduction: alirocumab and bococizumab
2015 HAYES, Inc. Peroral Endoscopic Myotomy (POEM) for treatment of esophageal achalasia
2015 HAYES, Inc. Primary endovascular mechanical thrombectomy for treatment of acute ischemic stroke
2015 HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: Simeprevir
2015 HAYES, Inc. Sonohysterography for assessment of abnormal uterine bleeding
2015 HAYES, Inc. Spinal cord stimulation for relief of neuropathic pain
2015 HAYES, Inc. Staged approach to sacral nerve stimulation for treatment of fecal incontinence
2015 HAYES, Inc. Total pancreatectomy with islet autotransplantation for chronic pancreatitis
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Perceval S sutureless valve for aortic valve replacement: a review of the clinical effectiveness, safety, and cost-effectiveness
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Rituximab for granulomatosis with polyangiitis or microscopic polyangiitis: a review of the clinical and cost-effectiveness
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Excimer laser and stenting in patients with distal peripheral arterial disease: a review of the clinical effectiveness, safety, and guidelines
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Holkira (ombitasvir/paritaprevir/ ritonavir with dasabuvir) and Harvoni (ledipasvir/sofosbuvir) for chronic hepatitis C: a review of the clinical evidence
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing in the general population: a review of the clinical and cost-effectiveness and guidelines
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Telehealth services for the treatment of psychiatric issues: clinical effectiveness, safety, and guidelines
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Electroconvulsive therapy performed outside of surgical suites: a review of the clinical effectiveness, safety, and guidelines
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Immediate osseointegrated implants for cancer patients: a review of clinical and cost-effectiveness
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Transoral robotic surgery: a review of clinical and cost-effectiveness
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Protein testing in patients with multiple myeloma: a review of clinical effectiveness and guidelines
2015 Canadian Agency for Drugs and Technologies in Health (CADTH) Stool antigen tests for helicobacter pylori infection: a review of clinical and cost-effectiveness and guidelines
2015 Health Quality Ontario (HQO) Paclitaxel drug-eluting stents in peripheral arterial disease: OHTAC recommendation
2015 Health Quality Ontario (HQO) Paclitaxel drug-eluting stents in peripheral arterial disease: a health technology assessment
2015 Technology Assessment at SickKids (TASK) Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective
2015 Haute Autorite de sante (HAS) [Rating trabecular bridging micro stents and their act of implanting]
2015 Haute Autorite de sante (HAS) [Reassessment of the eligibility criteria of transcather aortic valve implantation by transcutaneous blood or by transapical delivery]
2015 Haute Autorite de sante (HAS) [Corneal collagen cross-linking and intrastromal corneal ring segments in the treatment of corneal ectasia]
2015 Haute Autorite de sante (HAS) [Assessment of the measurement of cytomegalovirus viral load by gene amplification in allograft recipients]
2015 Haute Autorite de sante (HAS) [Gene amplification to detect herpes simplex virus (HSV) and varicella-zoster virus (VZV) genomes in cerebrospinal fluid in cases of encephalitis]
2015 Haute Autorite de sante (HAS) [Interferon-gamma release assays as in vitro screening tests for latent tuberculosis infection]
2015 Haute Autorite de sante (HAS) [Assessment of diagnostic and therapeutic parotid and submandibular sialendoscopy]
2015 Haute Autorite de sante (HAS) [Modification of the nomenclature of procedures in laboratory medicine for research into Treponema pallidum (bacteria responsible for syphilis)]
2015 Haute Autorite de sante (HAS) [Assessment of an edge-to-edge mitral valve repair clip and its implantation]
2015 Haute Autorite de sante (HAS) [Assessment of the safety and conditions for conducting autologous fat grafting in reconstructive, restorative and cosmetic breast surgery]
2015 Haute Autorite de sante (HAS) [Alternative(s) to 99mTc-sestamibi preoperative scintigraphy for the localization of hypersecreting parathyroid glands in the event of complete shortage of 99mTechnetium (99mTc)]
2015 Haute Autorite de sante (HAS) [Fractional flow reserve (FFR) measurement during coronary angiography]
2015 Haute Autorite de sante (HAS) [Measurement of nitric oxide (NO) in exhaled air]
2015 Haute Autorite de sante (HAS) [Rare visceral surgery procedures by laparoscopy]
2015 Malaysian Health Technology Assessment (MaHTAS) Kangaroo mother care
2015 Malaysian Health Technology Assessment (MaHTAS) Capsule endoscopy for colorectal cancer (CRC) screening
2015 Malaysian Health Technology Assessment (MaHTAS) Health risk Assessment (HRA) module for breast cancer
2015 NIHR Horizon Scanning Centre (NIHR HSC) Lonsurf (trifluridine and tipiracil hydrochloride) for metastatic colorectal cancer – third line
2015 NIHR Horizon Scanning Centre (NIHR HSC) AZD9291 for locally advanced or metastatic, EGFR and T790M mutation positive non-small cell lung cancer – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Sodium thiosulfate for prevention of hearing loss in children receiving cisplatin chemotherapy
2015 NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for small cell lung cancer – first line, in combination with etoposide and platinum therapy
2015 NIHR Horizon Scanning Centre (NIHR HSC) Selumetinib for metastatic uveal melanoma – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Ibrutinib (Imbruvica) for Waldenström's macroglobulinaemia
2015 NIHR Horizon Scanning Centre (NIHR HSC) Nimotuzumab for advanced pancreatic cancer – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Evofosfamide for locally advanced, unresectable or metastatic pancreatic cancer – first line in combination with gemcitabine
2015 NIHR Horizon Scanning Centre (NIHR HSC) Ixekizumab for moderate to severe chronic plaque psoriasis
2015 NIHR Horizon Scanning Centre (NIHR HSC) Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulators
2015 NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for amyotrophic lateral sclerosis – add-on therapy to riluzole
2015 NIHR Horizon Scanning Centre (NIHR HSC) Reslizumab for eosinophilic asthma
2015 NIHR Horizon Scanning Centre (NIHR HSC) Biotin (Cerenday) for primary and secondary progressive multiple sclerosis - first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Sodium zirconium cyclosilicate for hyperkalaemia – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Simeprevir in combination with sofosbuvir (with or without ribavirin) for chronic hepatitis C
2015 NIHR Horizon Scanning Centre (NIHR HSC) Sarilumab for moderate to severe active rheumatoid arthritis
2015 NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for chronic plaque psoriasis – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Cx601 (Alofisel®) for complex perianal fistula in adults with non-active or mildly-active luminal Crohn's disease – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Tildrakizumab for moderate to severe plaque psoriasis
2015 NIHR Horizon Scanning Centre (NIHR HSC) Natalizumab (Tysabri) for secondary progressive multiple sclerosis
2015 NIHR Horizon Scanning Centre (NIHR HSC) Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy
2015 NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (Brilique) for preventing thombotic events in patients with acute ischaemic stroke or high risk transient ischaemic attack
2015 NIHR Horizon Scanning Centre (NIHR HSC) APN311 for high risk neuroblastoma in children and adolescents – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Atezolizumab for urothelial bladder cancer – second and subsequent line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Brentuximab vedotin (Adcetris) for CD30-positive cutaneous T-cell lymphoma
2015 NIHR Horizon Scanning Centre (NIHR HSC) Buparlisib in combination with fulvestrant for hormone-receptor positive/HER2-negative locally advanced or metastatic breast cancer
2015 NIHR Horizon Scanning Centre (NIHR HSC) Cabozantinib (Cometriq) for metastatic renal cell carcinoma –second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Elotuzumab with lenalidomide for multiple myeloma – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Neratinib with capecitabine for advanced or metastatic HER2-positive breast cancer – third line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Palbociclib for advanced or metastatic, oestrogen-receptor positive, HER2-negative, recurrent breast cancer – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Vandetanib (Caprelsa) for locally advanced or metastatic differentiated thyroid cancer – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Vemurafenib (Zelboraf) for metastatic BRAF V600 mutation positive melanoma in children and adolescents
2015 NIHR Horizon Scanning Centre (NIHR HSC) GS-6615 for long QT-3 syndrome
2015 NIHR Horizon Scanning Centre (NIHR HSC) Holoclar for the treatment of limbal stem cell deficiency due to ocular burns
2015 NIHR Horizon Scanning Centre (NIHR HSC) Midodrine (Bramox) for orthostatic hypotension
2015 NIHR Horizon Scanning Centre (NIHR HSC) Tenofovir alafenamide monotherapy for hepatitis B
2015 NIHR Horizon Scanning Centre (NIHR HSC) Baricitinib for moderate to severe rheumatoid arthritis
2015 NIHR Horizon Scanning Centre (NIHR HSC) Certolizumab (Cimzia) for early rheumatoid arthritis – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for psoriatic arthritis – second or subsequent line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Patiromer for hyperkalaemia – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Alectinib for advanced ALK-positive, non-small cell lung cancer – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Alectinib for locally advanced or metastatic ALK-positive, non-small cell lung cancer following failure of crizotinib